Hereditary erythromelalgia in an adolescent. Clinical observation of a rare disease
- Authors: Toriya V.G.1, Savina M.V.1, Vissarionov S.V.1, Baindurashvili A.G.1
-
Affiliations:
- H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery
- Issue: Vol 10, No 1 (2022)
- Pages: 85-92
- Section: Clinical cases
- URL: https://journals.rcsi.science/turner/article/view/90396
- DOI: https://doi.org/10.17816/PTORS90396
- ID: 90396
Cite item
Abstract
BACKGROUND: Erythromelalgia is a severe, chronic, progressive disease with periods of exacerbation and remission. A triad of symptoms characterizes the disease: reddening of the extremities, a local increase in skin temperature, and pronounced neuropathic pain syndrome. There are sporadic works in the Russian literature that present data on erythromelalgia, particularly in children. The publications are descriptions of clinical observations with the assessment of the clinical picture of the patient regarding cutaneous manifestations and surgical care at the time of hospitalization, time spent in the hospital, and during the period of his chronic disease exacerbation.
CLINICAL CASE: A clinical case of hereditary erythromelalgia in a 15-year-old adolescent with a detailed description of the disease course since the initial manifestation is presented.
DISCUSSION: During three and a half years, despite early diagnosis and application of consistent pharmacotherapy including nonsteroidal anti-inflammatory drugs, antidepressants, anticonvulsants, antihistamines, opioids, hormonal therapy, local use of lidocaine, ointment with silver content, the disease was progressive, with the resistance of pain syndrome to the treatment, with periods of exacerbation and partial remission.
CONCLUSIONS: The presented clinical observations show the need to assess the patient as a chronic and intractable patient. Considering the lack of understanding of the apparent cause of this disease and its diverse manifestations in the clinical picture, a multidisciplinary approach with a search for new treatment methods, including neurosurgical techniques of chronic pain treatment, is required for patients with erythromelalgia.
Full Text
##article.viewOnOriginalSite##About the authors
Vachtang G. Toriya
H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery
Author for correspondence.
Email: vakdiss@yandex.ru
ORCID iD: 0000-0002-2056-9726
SPIN-code: 1797-5031
MD, Neurosurgeon
Russian Federation, Saint PetersburgMargarita V. Savina
H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery
Email: drevma@yandex.ru
ORCID iD: 0000-0001-8225-3885
SPIN-code: 5710-4790
Scopus Author ID: 57193277614
MD, PhD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgSergei V. Vissarionov
H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery
Email: vissarionovs@gmail.com
ORCID iD: 0000-0003-4235-5048
SPIN-code: 7125-4930
Scopus Author ID: 6504128319
ResearcherId: P-8596-2015
MD, PhD, Dr. Sci. (Med.), Professor, Corresponding Member of RAS
Russian Federation, Saint PetersburgAlexey G. Baindurashvili
H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery
Email: turner011@mail.ru
ORCID iD: 0000-0001-8123-6944
SPIN-code: 2153-9050
Scopus Author ID: 6603212551
MD, PhD, Dr. Sci. (Med.), Professor, Member of RAS, Honored Doctor of the Russian Federation
Russian Federation, Saint PetersburgReferences
- Mitchell SW. On a rare vaso-motor neurosis of the extremities and on the mala-dies with which it may be confounded. Am J Med Sci. 1878;76:17–36.
- Dib-Hajj SD, Yang Y, Waxman SG. Genetics and molecular pathophysiology of Na(v)1.7-related pain syndromes. Adv Genet. 2008;63:85–110.
- Heidrich H. Functional vascular diseases: Raynaud’s syndrome, acrocyanosis and erythromelalgia. Vasa. 2010;39(1):33–41. doi: 10.1024/0301-1526/a000003
- Parker LK, Ponte C, Howell KJ, et al. Clinical features and management of erythromelalgia: long-term follow-up of 46 cases. Clin Exp Rheumatol. 2017;35:80–84.
- Tamrazova OB, Molochkov AV, Koren’kova OV, Novikov KA. The angiotrophoneuroses. Erythromelalgia in a 11-year old child. Almanac of Clinical Medicine. 2016;44(1):52–57. (In Russ.). doi: 10.18786/2072-0505-2016-44-1-52-57
- Mcdonnell A, Schulman B, Ali Z, et al. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile. Brain. 2016;139(4):1052–1065. doi: 10.1093/brain/aww007
- Samoilenko IG, Chernyshova OE, Dolynskyi VV. Idiopathic manifestation of Mitchell’s syndrome (erythromelalgia) in a child. Child’s Health. 2016;(3):121–123. (In Russ.)
- Parhomenko EV, Sorokina EA. Klinicheskiy sluchay: eritromelalgiya. Rossiyskiy zhurnal boli. 2019;17(S1):20–21. (In Russ.)
- Shchava SN. Klinicheskiy sluchay eritromelalgii (sindrom Mitchella) – redkogo vazomatornogo nevroza konechnostey. Klinicheskaya dermatologiya i venerologiya. 2013;11(2):28–29. (In Russ.)
- Friberg D, Chen T, Tarr G, van Rij A. Erythromelalgia? A clinical study of people who experience red, hot, painful feet in the community. Int J Vasc Med. 2013;2013(2):864961. doi: 10.1155/2013/864961
- Tham SW, Giles M. Current pain management strategies for patients with erythromelalgia: a critical review. J Pain Res. 2018;11:1689–1698. doi: 10.2147/JPR.S154462
- Ueda H. Molecular mechnisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther. 2006;109(1–2):57–77. doi: 10.1016/j.pharmthera.2005.06.003
- Orstavic K, Jorum E. Microneurographic findings of relevance of pain in patients with erythromelalgia and patients with diabetic neuropathy. Neurosci Lett. 2010;470(3):180–184. doi: 10.1016/j.neulet.2009.05.061
Supplementary files
